| 000 | 01561 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517124322.0 | ||
| 264 | 0 | _c20180118 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a2325-6621 | ||
| 024 | 7 |
_a10.1513/AnnalsATS.201606-436OC _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLongphre, Malinda V | |
| 245 | 0 | 0 |
_aClinical Bioequivalence of OT329 SOLIS and ADVAIR DISKUS in Adults with Asthma. _h[electronic resource] |
| 260 |
_bAnnals of the American Thoracic Society _c02 2017 |
||
| 300 |
_a182-189 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluticasone-Salmeterol Drug Combination _xtherapeutic use |
| 650 | 0 | 4 |
_aForced Expiratory Volume _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aGetz, Elise Burmeister | |
| 700 | 1 | _aFuller, Rick | |
| 773 | 0 |
_tAnnals of the American Thoracic Society _gvol. 14 _gno. 2 _gp. 182-189 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1513/AnnalsATS.201606-436OC _zAvailable from publisher's website |
| 999 |
_c26608008 _d26608008 |
||